1-(2,3-Dihydro-5-methyl-1H-pyrrolizin-7-yl)ethanone

Metabolite details

Identifier

DJAGDEJXGVMMGJ-UHFFFAOYSA-N

InChI Key

DJAGDEJXGVMMGJ-UHFFFAOYSA-N

IUPAC name

1-(3-methyl-6,7-dihydro-5H-pyrrolizin-1-yl)ethanone

Preferred name

1-(2,3-Dihydro-5-methyl-1H-pyrrolizin-7-yl)ethanone

INN name

—

Synonym

—

ChEBI

CHEBI:173434

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day